We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+11.75%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$65.7B
AUM Growth
+$6.62B
Cap. Flow
+$648M
Cap. Flow %
0.99%
Top 10 Hldgs %
27.2%
Holding
2,939
New
828
Increased
695
Reduced
744
Closed
553

Top Sells

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$400M
2
STZ icon
Constellation Brands
STZ
+$345M
3
META icon
Meta Platforms (Facebook)
META
+$286M
4
KVUE icon
Kenvue
KVUE
+$277M
5
ABBV icon
AbbVie
ABBV
+$258M

Sector Composition

Rank Sector Weight
1 Technology 16.4%
2 Healthcare 13.22%
3 Consumer Discretionary 12.71%
4 Financials 7.66%
5 Communication Services 7.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAK icon
2101
Braskem
BAK
$980M
$291K ﹤0.01%
27,608
-74,195
-73% -$605K
AU icon
2102
AngloGold Ashanti
AU
$39.7B
$290K ﹤0.01%
13,056
-42,129
-76% -$794K
LCUT icon
2103
Lifetime Brands
LCUT
$197M
$290K ﹤0.01%
+27,626
New +$243K
KEY icon
2104
KeyCorp
KEY
$24.2B
$289K ﹤0.01%
18,300
-1,091,907
-98% -$15.8M
MSGE icon
2105
Madison Square Garden
MSGE
$3.68B
$289K ﹤0.01%
+7,374
New +$263K
EQBK icon
2106
Equity Bancshares
EQBK
$1.05B
$289K ﹤0.01%
+8,399
New +$274K
INGR icon
2107
Ingredion
INGR
$6.56B
$288K ﹤0.01%
+2,465
New +$278K
MLI icon
2108
Mueller Industries
MLI
$14.3B
$286K ﹤0.01%
+10,600
New +$262K
BLKB icon
2109
Blackbaud
BLKB
$1.67B
$282K ﹤0.01%
+3,800
New +$290K
TDAY
2110
USA Today Co
TDAY
$1.24B
$282K ﹤0.01%
115,411
-169,202
-59% -$380K
BXP icon
2111
Boston Properties
BXP
$11B
$281K ﹤0.01%
4,307
-65,858
-94% -$4.36M
TTSH
2112
DELISTED
Tile Shop Holdings
TTSH
$279K ﹤0.01%
+39,681
New +$268K
VSTO
2113
DELISTED
Vista Outdoor Inc.
VSTO
$276K ﹤0.01%
8,429
-50,118
-86% -$1.52M
OWL icon
2114
Blue Owl Capital
OWL
$6.54B
$275K ﹤0.01%
14,600
-174,322
-92% -$2.92M
ASML icon
2115
CALL
ASML
ASML
$602B
$275K ﹤0.01%
+300
New +$266K
VNDA icon
2116
Vanda Pharmaceuticals
VNDA
$307M
$274K ﹤0.01%
66,645
-120,852
-64% -$484K
KLRS
2117
Kalaris Therapeutics
KLRS
$84M
$274K ﹤0.01%
15,875
+1,759
+12% +$28.7K
FMS icon
2118
Fresenius Medical Care
FMS
$13.3B
$273K ﹤0.01%
+14,156
New +$281K
BAER icon
2119
Bridger Aerospace
BAER
$108M
$273K ﹤0.01%
+54,310
New +$301K
HD icon
2120
PUT
Home Depot
HD
$346B
$272K ﹤0.01%
800
-11,300
-93% -$4.13M
TRTL.WS
2121
CALL
DELISTED
TortoiseEcofin Acquisition Corp. III Warrant, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
TRTL.WS
$272K ﹤0.01%
25,000
EIS icon
2122
iShares MSCI Israel ETF
EIS
$878M
$271K ﹤0.01%
+4,251
New +$257K
CRI icon
2123
Carter's
CRI
$1.46B
$271K ﹤0.01%
+3,200
New +$254K
OTLY
2124
Oatly Group
OTLY
$468M
$271K ﹤0.01%
11,985
-5,112
-30% -$115K
SONDW
2125
CALL
DELISTED
Sonder Holdings Inc Warrants
SONDW
$270K ﹤0.01%
75,000

Similar funds

Marshall Wace's Q1 2024 Portfolio in Review

As of Q1 2024, Marshall Wace held 2,939 positions worth $65.7B, up 11% from $59B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Marshall Wace's Q1 2024 filing shows 828 new, 695 increased, 744 reduced and 553 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 900,000 shares worth $433M. The largest sale was Walmart Inc, an estimated $400M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Marshall Wace's largest Q1 2024 buy was Vanguard S&P 500 ETF: 900,000 shares worth $433M.
  • Marshall Wace added most to Goldman Sachs in Q1 2024, an estimated $374M increase.
  • Marshall Wace's biggest Q1 2024 reduction was Walmart Inc, cutting an estimated $400M.
  • Marshall Wace fully exited Celsius Holdings in Q1 2024, selling an estimated $143M.
  • Marshall Wace's ten largest holdings make up 27% of its $65.7B portfolio in Q1 2024.
  • Marshall Wace opened 828 new positions and closed 553 in Q1 2024.
  • Marshall Wace's portfolio value rose 11% quarter-over-quarter to $65.7B.

Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.